Sponsor Pipeline

Goldman, Butterwick, Fitzpatrick and Groff Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
12
Active Trials
0
Recruiting
3
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 4
2
Phase 2/3
3
Phase 2
3
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07342413 Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1%… Leg Veins Not Yet Recruiting
NCT07421544 Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and… Fine Lines Not Yet Recruiting
Phase 2/3
NCT06603857 Skin Care Regimen for Improving Photoaging Signs on the Face Improve Photoaging Signs Not Yet Recruiting
NCT06638905 Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin Facial Wrinkles Not Yet Recruiting
NCT07686198 Study Comparing Two Serums With Intense Pulsed Light for the Treatment of Moderate to… Photodamaged Skin Not Yet Recruiting
Phase 2
NCT07217743 Assess Impact of Poly-L-lactic Acid on GLP1 Subjects Laxity; Skin Not Yet Recruiting
NCT07221461 Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on… Wrinkle Not Yet Recruiting
NCT07462533 Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing Skin Laxity Not Yet Recruiting
Not specified
NCT06926023 1550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of… Female Pattern Baldness Not Yet Recruiting
NCT06656923 Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH… Lateral Gluteal Depression Active, Not Recruiting
NCT07216352 Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible… Laxity; Skin Not Yet Recruiting
NCT07558603 Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone… Laxity; Skin Not Yet Recruiting
Disease Areas
Get alerts when Goldman, Butterwick, Fitzpatrick and Groff's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free